Speakers

Speakers

Greg Holgate, Biocatalysis Chemist, Sterling Pharma Solutions Ltd

photo of Greg Holgate

Born in Frankfurt am Main, Germany to British/Russian parents. He moved to Gateshead, North East England at a young age. There he grew up, and developed a passion for natural sciences. Subsequently, he would be accepted into Newcastle University to study for a Masters degree in Chemistry with Medicinal Chemistry. During this time, he experienced a year working in industry at AkzoNobel, where he developed non-biocidal antifouling coatings for large ships and vessels. After graduating, he joined Sterling Pharma Solutions as a Knowledge Transfer Partnership (KTP) associate within of the Innovate UK programme. Alongside Northumbria University, he worked to knowledge transfer the use of enzymes for API manufacture to site; where he would go on to build a small scale enzyme screening laboratory. He would eventually join Sterling permanently as a Biocatalysis Chemist, working on chemoenzymatic synthesis of pharmaceuticals and enzymatic process development, in a role he continues to work in today.

Presentation Title: Enzymes: Biocatalysts for innovative small molecule production

Abstract: Sterling Pharma Solutions are a leading supplier of API services to the pharmaceutical industry. Operating in this space comes with responsibility, and an obligation to keep pace with the ever changing innovation landscape. As a partnership development and manufacturing organisation (PDMO), Sterling recognise the importance of a strong collaboration framework in delivering for our customers. With this in mind, todays talk will explore Sterling's technology infrastructure, with a concept-to-delivery approach described. Biocatalysis, the use of enzymes for molecule manufacture, will be utilised as a case study for this exploration.

View company profile